Talphera, Inc. TLPH
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- -9.65%
- 1 year
- -16.94%
- Open
- 1.07
- Prev close
- 1.07
- Mkt cap
- 53.46M
- Vol
- 83.50K
- Avg vol
- 176.22K
- EPS
- -0.26
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.03
- High
- 1.08
- Forward P/E
- -0.63
- Beta
- 0.30
- Short ratio
- 0.85
- Inst. own
- 29.80%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.8056
- 200-d avg
- 0.93205
- 1y target
- 4.17
5D chart
Signals (34)
| Name | Time | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 30, 12:35 PM | 2 days ago |
| RSI: Oversold | Oct 30, 12:35 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 12:15 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 11:30 AM | 2 days ago |
| RSI: Oversold | Oct 30, 11:30 AM | 2 days ago |
| MACD: Buy Signal | Oct 30, 9:45 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 3:50 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 1:05 PM | 3 days ago |
| RSI: Oversold | Oct 29, 12:00 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 11:25 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 11:05 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 10:25 AM | 3 days ago |
| SMA: Bullish | Oct 29, 9:30 AM | 3 days ago |
| SMA: Bullish | Oct 29, 9:30 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 9:30 AM | 3 days ago |
| RSI: Overbought | Oct 29, 9:30 AM | 3 days ago |
| MACD: Sell Signal | Oct 28, 3:45 PM | 4 days ago |
| RSI: Oversold | Oct 28, 3:45 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:30 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 1:15 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 11:20 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 10:55 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 10:25 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 10:05 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 10:00 AM | 4 days ago |
| SMA: Bullish | Oct 28, 9:55 AM | 4 days ago |
| RSI: Oversold | Oct 27, 3:55 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 12:05 PM | 5 days ago |
| RSI: Overbought | Oct 27, 9:55 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 9:45 AM | 5 days ago |
| MACD: Sell Signal | Oct 26, 2:50 PM | 6 days ago |
| RSI: Overbought | Oct 26, 1:45 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 1:15 PM | 6 days ago |
| RSI: Oversold | Oct 26, 11:55 AM | 6 days ago |
News
3 weeks ago defenseworld.net
Head to Head Comparison: ANI Pharmaceuticals (NASDAQ:ANIP) and Talphera (NASDAQ:TLPH)
Talphera (NASDAQ: TLPH - Get Free Report) and ANI Pharmaceuticals (NASDAQ: ANIP - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will contrast the two…
1 month ago zacks.com
Talphera (TLPH) Upgraded to Buy: Here's What You Should Know
Talphera (TLPH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
1 month ago prnewswire.com
Talphera to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
SAN MATEO, Calif., Sept. 3, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative…
2 months ago seekingalpha.com
Talphera, Inc. (TLPH) Q2 2026 Earnings Call Transcript
Talphera, Inc. (TLPH) Q2 2026 Earnings Call Transcript
-
2 months ago benzinga.com
Talphera Q2 EPS $(0.06) Beats $(0.07) Estimate
Talphera (NASDAQ:TLPH) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.07) by 14.29 percent. This is a 40 percent increase over losses of $(0.10) per…
2 months ago prnewswire.com
Talphera Announces Second Quarter 2026 Financial Results and Provides Corporate Update
NEPHRO CRRT clinical study of nafamostat is 75% enrolled; expected to be complete this year Draft 2026 KDIGO guidelines added nafamostat as an acceptable CRRT anticoagulant, a positive change from…
2 months ago prnewswire.com
Talphera to Report Second Quarter 2026 Financial Results on Wednesday, August 12, 2026
SAN MATEO, Calif., Aug. 5, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative…
4 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's Intraday Session
-
4 months ago benzinga.com
HC Wainwright & Co. Assumes Talphera at Buy, Announces Price Target of $3
HC Wainwright & Co. analyst Brandon Folkes assumes Talphera (NASDAQ:TLPH) with a Buy rating and announces Price Target of $3.
5 months ago seekingalpha.com
Talphera, Inc. (TLPH) Q1 2026 Earnings Call Transcript
Talphera, Inc. (TLPH) Q1 2026 Earnings Call Transcript
5 months ago benzinga.com
Talphera Q1 2026 Earnings Call Transcript
Talphera Q1 2026 Earnings Call Transcript
-
5 months ago benzinga.com
Talphera Q1 EPS $(0.04) Beats $(0.07) Estimate, Sales $0.00 Down From $27.000K YoY
Talphera (NASDAQ:TLPH) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.07) by 42.86 percent. This is a 60 percent increase over losses of $(0.10) per…
5 months ago prnewswire.com
Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update
NEPHRO CRRT clinical study expected to be completed this year Cash and investments of $21.1 million at March 31, 2026 Conference call and webcast to be held on Wednesday, May 13, 2026 at 4:30 pm ET…
5 months ago prnewswire.com
Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 13, 2026
SAN MATEO, Calif., May 7, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies…
-
6 months ago benzinga.com
WestPark Capital Initiates Coverage On Talphera with Buy Rating, Announces Price Target of $3
WestPark Capital analyst Ed Arce initiates coverage on Talphera (NASDAQ:TLPH) with a Buy rating and announces Price Target of $3.
-
6 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
12 Health Care Stocks Moving In Thursday's Pre-Market Session
6 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
-
6 months ago benzinga.com
9 Health Care Stocks Moving In Wednesday's Pre-Market Session
9 Health Care Stocks Moving In Wednesday's Pre-Market Session
7 months ago prnewswire.com
Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026
SAN MATEO, Calif., March 25, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative…
7 months ago defenseworld.net
Talphera Q4 Earnings Call Highlights
Talphera (NASDAQ: TLPH) used a virtual analyst and investor event to provide a business update and to highlight what company leaders and two clinical experts described as an unmet need in…
7 months ago seekingalpha.com
Talphera, Inc. (TLPH) Analyst/Investor Day Transcript
Talphera, Inc. (TLPH) Analyst/Investor Day Transcript
-
7 months ago benzinga.com
Talphera Q4 EPS $(0.06) Beats $(0.14) Estimate
Talphera (NASDAQ:TLPH) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.14) by 57.14 percent. This is a 14.29 percent increase over losses of $(0.07)…
7 months ago prnewswire.com
Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Previously announced achievement of 50% enrollment of the NEPHRO CRRT clinical study in March 2026 and closed the associated financing tranche of $4.1 million All 12 clinical study sites now able to…
7 months ago prnewswire.com
Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026
SAN MATEO, Calif., March 18, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative…
-
8 months ago benzinga.com
Talphera Announces 50% Patient Enrollment Of NEPHRO-CRRT Clinical Trial
Enrolled 35 of the 70 patients in the ongoing NEPHRO-CRRT registrational study, supported by new target profile sitesCompany to host a virtual investor and analyst event on March 23 at 11:00 am ET…
8 months ago prnewswire.com
Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial
Enrolled 35 of the 70 patients in the ongoing NEPHRO-CRRT registrational study, supported by new target profile sites Company to host a virtual investor and analyst event on March 23 at 11:00 am ET…
8 months ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
-
8 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
8 months ago defenseworld.net
Talphera (NASDAQ:TLPH) Insider Purchases $28,350.00 in Stock
Talphera, Inc. (NASDAQ: TLPH - Get Free Report) insider Badri Dasu purchased 35,000 shares of the business's stock in a transaction on Thursday, February 12th. The shares were purchased at an average…
8 months ago defenseworld.net
Insider Buying: Talphera (NASDAQ:TLPH) Insider Acquires $28,350.00 in Stock
Talphera, Inc. (NASDAQ: TLPH - Get Free Report) insider Shakil Aslam purchased 35,000 shares of the company's stock in a transaction dated Thursday, February 12th. The stock was bought at an average…
8 months ago defenseworld.net
Insider Buying: Talphera (NASDAQ:TLPH) CFO Buys $36,450.00 in Stock
Talphera, Inc. (NASDAQ: TLPH - Get Free Report) CFO Raffi Asadorian acquired 45,000 shares of the company's stock in a transaction that occurred on Thursday, February 12th. The stock was purchased at…
8 months ago defenseworld.net
Talphera (NASDAQ:TLPH) Shares Down 0.3% – Here’s What Happened
Talphera, Inc. (NASDAQ: TLPH - Get Free Report)'s share price fell 0.3% on Thursday. The company traded as low as $0.7808 and last traded at $0.8079. 39,878 shares traded hands during trading, a…
-
8 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
10 months ago defenseworld.net
Talphera (NASDAQ:TLPH) Stock Price Down 2.7% – Here’s Why
Talphera, Inc. (NASDAQ: TLPH - Get Free Report)'s stock price fell 2.7% during trading on Monday. The company traded as low as $1.04 and last traded at $1.07. 189,221 shares were traded during…
-
11 months ago benzinga.com
Talphera Q3 EPS $(0.11) Beats $(0.13) Estimate, Sales $1.000K
Talphera (NASDAQ:TLPH) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.13) by 12 percent. This is a 15.38 percent increase over losses of $(0.13) per…
-
11 months ago benzinga.com
Earnings Scheduled For November 12, 2025
Earnings Scheduled For November 12, 2025
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
1 year ago benzinga.com
Why Nebius Group Shares Are Trading Higher By Around 50%; Here Are 20 Stocks Moving Premarket
Why Nebius Group Shares Are Trading Higher By Around 50%; Here Are 20 Stocks Moving Premarket
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session
-
1 year ago benzinga.com
Earnings Scheduled For August 14, 2025
Earnings Scheduled For August 14, 2025
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
-
1 year ago benzinga.com
Earnings Scheduled For November 13, 2024
Earnings Scheduled For November 13, 2024
-
2 years ago benzinga.com
Earnings Scheduled For March 6, 2024
Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million.
-
2 years ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session